|Critical Alert, of Jacksonville, Fla.||Commonpath Enterprise Software||Software-as-a-service platform||Provides intelligent routing of patient events and medical device alarms for hospitals and health care systems||Received U.S. FDA clearance as a class II medical device|
|Eko Devices Inc., of Oakland, Calif.||ECG Low Ejection Fraction Tool||Algorithm-based software||Detects whether a patient has a left ventricular ejection fraction less than or equal to 40% based upon the analysis of electrocardiogram (ECG) signals at the point of care||Received emergency use authorization from the U.S. FDA to assist providers in identifying patients with abnormal heart function during the COVID-19 pandemic|
|Novocure Ltd., of St. Helier, Jersey, and Zai Lab Ltd., of Shanghai||Optune||Delivers Tumor Treating Fields therapy||For use in combination with temozolomide for the treatment of patients with newly diagnosed glioblastoma (GBM) and as a monotherapy for the treatment of patients with recurrent GBM||China's National Medical Products Administration approved the marketing authorization application|
|Optina Diagnostics, of Montreal||Mydriatic Hyperspectral Retinal Camera (MHRC-C1)||Provides a series of monochromatic images obtained in less than 1 second||For capturing images of the retina at multiple wavelengths under mydriatic conditions||Received 510(k) clearance from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.